Skip to main content
Clinical Trials/ChiCTR1900022178
ChiCTR1900022178Not yet recruitingPhase 4

静脉输注利多卡因对无痛支气管镜检查中丙泊酚剂量的影响:一项随机对照研究

政府资助1 site in 1 country60 target enrollmentStarted: April 1, 2019Last updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
丙泊酚用量

Study Overview

Brief Summary

观察静脉输注利多卡因在无痛气管镜中,是否减少丙泊酚及阿片类药物的需求量。

Study Design

Study Type
干预性研究
Primary Purpose
随机平行对照
Masking
N/a

Eligibility Criteria

Ages
18 to 80 (—)
Sex
All

Inclusion Criteria

  • 1.同意接受无痛支气管镜检查的患者
  • 2.ASA I~III 级
  • 3.年龄≥18 岁,男女不限

Exclusion Criteria

  • 3、病情危重(术前 ASA 分级≥IV 级者);严重肾功能损害(术前接受透析治疗);严重肝功能损害(Child-Pugh C 级)者;术前合并严重心脏疾患,LVEF<30%者;
  • 4、盐酸丙泊酚注射液过敏史
  • 5、术前应用潜在影响神经调节药物(安定等)
  • 6、对阿片类药物不耐受者
  • 7、颅脑损伤或神外科手术史

Arms & Interventions

静脉输注利多卡因组

静脉输注利多卡因

对照组

生理盐水

Outcomes

Primary Outcomes

丙泊酚用量

Time Frame: 手术结束时

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
政府资助

Study Sites (1)

Loading locations...

Similar Trials